Advanced search
Publication Cover
OncoImmunology Volume 1, 2012 - Issue 2
Submit an article Journal homepage
899
Views
18
CrossRef citations to date
0
Altmetric
Author's View

Systemic cancer immunotherapy with Toll-like receptor 7 agonists

Timing is everything

Christian Hotz Center for Integrated Protein Science Munich (CIPSM); Division of Clinical Pharmacology; Department of Internal Medicine; Ludwig-Maximilian University of Munich; Munich, Germany; Department of Medicine; University of Fribourg; Fribourg, Switzerland
&
Carole Bourquin Center for Integrated Protein Science Munich (CIPSM); Division of Clinical Pharmacology; Department of Internal Medicine; Ludwig-Maximilian University of Munich; Munich, Germany; Department of Medicine; University of Fribourg; Fribourg, SwitzerlandCorrespondence[email protected]
Pages 227-228 | Published online: 01 Mar 2012

Figures & data

Figure 1. Overview of the cellular mechanisms of TLR7-targeting therapy. DC: dendritic cell, Teff: effector T cells, Treg: regulatory T cell, MDSC: myeloid-derived suppressor cell, NK: natural killer cell, ssRNA: single-stranded RNA.

Figure 1. Overview of the cellular mechanisms of TLR7-targeting therapy. DC: dendritic cell, Teff: effector T cells, Treg: regulatory T cell, MDSC: myeloid-derived suppressor cell, NK: natural killer cell, ssRNA: single-stranded RNA.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.